Table of Content

1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 RESEARCH LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER)
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 GENE EXPRESSION ANALYSIS INDUSTRY: CAGR PROJECTIONS (2024–2029)
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 GENE EXPRESSION ANALYSIS INDUSTRY, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 15 GEOGRAPHIC SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 MARKET OVERVIEW 
          FIGURE 16 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET
    4.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS INDUSTRY, BY PRODUCT & SERVICE, 2023 
          FIGURE 17 PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.3 MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029 
          FIGURE 18 PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Advancements in gene editing technologies
                    5.2.1.2 Increasing funding initiatives for genomic research
                    5.2.1.3 Growing preference for therapeutic applications
                    5.2.1.4 Declining costs of sequencing technologies
                                FIGURE 21 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2022
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of instruments & consumables
                    5.2.2.2 Concerns associated with data privacy and security
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth potential across non-clinical applications
                    5.2.3.2 Machine learning and AI
                    5.2.3.3 Growing focus on single-cell analysis
           5.2.4 CHALLENGES
                    5.2.4.1 Extensive timelines for product approval
                    5.2.4.2 Data interpretation challenges
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 22 REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES
    5.4 PRICING ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
                    TABLE 4 GENE EXPRESSION ANALYSIS PRODUCT PRICE
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 23 GENE EXPRESSION ANALYSIS INDUSTRY: VALUE CHAIN ANALYSIS
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 24 MARKET: SUPPLY CHAIN ANALYSIS
          TABLE 5 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 25 MARKET ECOSYSTEM
           5.7.1 MARKET: REAGENT & CONSUMABLE VENDORS
                    TABLE 6 MARKET: REAGENT & CONSUMABLE VENDORS
           5.7.2 MARKET: INSTRUMENT VENDORS
                    TABLE 7 MARKET: INSTRUMENT VENDORS
           5.7.3 MARKET: END USERS
                    TABLE 8 MARKET: END USERS
           5.7.4 MARKET: REGULATORY BODIES
                    TABLE 9 MARKET: REGULATORY BODIES
    5.8 TECHNOLOGY ANALYSIS 
    5.9 PATENT ANALYSIS 
           5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
                    TABLE 10 PATENTS FILED, 2014–2024
           5.9.2 INNOVATION & PATENT APPLICATIONS
                    FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023
           5.9.3 TOP APPLICANTS
                    FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
                    FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
                    TABLE 11 TOP 12 PATENT OWNERS IN MARKET, 2014–2024
                    TABLE 12 PATENTS IN MARKET (2024)
    5.10 TRADE DATA 
           5.10.1 INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS
                     TABLE 13 IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS)
                     TABLE 14 EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS)
           5.10.2 MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS
                     TABLE 15 IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS)
                     TABLE 16 EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS)
    5.11 KEY CONFERENCES & EVENTS 
           5.11.1 MARKET: CONFERENCES & EVENTS IN 2024–2025
                     TABLE 17 GENE EXPRESSION ANALYSIS INDUSTRY: CONFERENCES & EVENTS (2024–2025)
    5.12 REGULATORY LANDSCAPE 
           5.12.1 CBER REGULATIONS ON GENE EXPRESSION ANALYSIS
           5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 21 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 22 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 BARGAINING POWER OF SUPPLIERS
           5.13.5 INTENSITY OF COMPETITIVE RIVALRY
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES
                     TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
           5.14.2 BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS
                     FIGURE 30 KEY BUYING CRITERIA FOR END USERS
                     TABLE 24 KEY BUYING CRITERIA FOR TOP FOUR END USERS
6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE (Page No. - 93)
    6.1 INTRODUCTION 
          TABLE 25 GENE EXPRESSION ANALYSIS INDUSTRY, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
    6.2 REAGENTS & CONSUMABLES 
          TABLE 26 MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 27 MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
          TABLE 28 NORTH AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 29 EUROPE: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 30 ASIA PACIFIC: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 31 LATIN AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 32 MIDDLE EAST: MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
          TABLE 33 GCC COUNTRIES: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.1 ASSAYS & KITS
                    6.2.1.1 Growing demand for streamlined and user-friendly solutions to drive market
                                TABLE 34 MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 35 NORTH AMERICA: MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 36 EUROPE: MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 37 ASIA PACIFIC: MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 38 LATIN AMERICA: MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 39 MIDDLE EAST: MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 40 GCC COUNTRIES: MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.2 ENZYMES
                    6.2.2.1 High uptake in molecular techniques to drive market
                                TABLE 41 MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 42 NORTH AMERICA: MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 43 EUROPE: MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 44 ASIA PACIFIC: MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 45 LATIN AMERICA: MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 46 MIDDLE EAST: MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 47 GCC COUNTRIES: MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.3 DNA CHIPS
                    6.2.3.1 Rising demand across forensic research applications to propel market
                                TABLE 48 MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 49 NORTH AMERICA: MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 50 EUROPE: MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 51 ASIA PACIFIC: MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 52 LATIN AMERICA: MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 53 MIDDLE EAST: MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 54 GCC COUNTRIES: MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.4 OTHER REAGENTS & CONSUMABLES
                    TABLE 55 MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 56 NORTH AMERICA: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 57 EUROPE: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 59 LATIN AMERICA: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 60 MIDDLE EAST: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 61 GCC COUNTRIES: MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 INSTRUMENTS 
          TABLE 62 MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 63 MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 64 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 65 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 66 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 67 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 68 MIDDLE EAST: MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 69 GCC COUNTRIES: MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 PCR
                    6.3.1.1 Growing focus on development of novel PCR kits to boost demand
                                TABLE 70 GENE EXPRESSION ANALYSIS INDUSTRY FOR PCR, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 71 NORTH AMERICA: MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 72 EUROPE: MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 73 ASIA PACIFIC: MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 74 LATIN AMERICA: MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 75 MIDDLE EAST: MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 76 GCC COUNTRIES: MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 NGS
                    6.3.2.1 Increasing investments in advanced technologies to drive market
                                TABLE 77 GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 78 NORTH AMERICA: MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 79 EUROPE: MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 80 ASIA PACIFIC: MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 81 LATIN AMERICA: MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 82 MIDDLE EAST: MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 83 GCC COUNTRIES: MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 DNA MICROARRAYS
                    6.3.3.1 High-throughput capabilities to propel market
                                TABLE 84 MARKET FOR DNA MICROARRAYS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 85 NORTH AMERICA: MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 86 EUROPE: MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 87 ASIA PACIFIC: MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 88 LATIN AMERICA: MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 89 MIDDLE EAST: MARKET FOR DNA MICROARRAYS, BY REGION 2022–2029 (USD MILLION)
                                TABLE 90 GCC COUNTRIES: MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.4 OTHER INSTRUMENTS
                    TABLE 91 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 92 NORTH AMERICA: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 93 EUROPE: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 94 ASIA PACIFIC: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 95 LATIN AMERICA: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 96 MIDDLE EAST: MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 97 GCC COUNTRIES: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
    6.4 SERVICES 
          TABLE 98 MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 99 MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)
          TABLE 100 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 101 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 102 ASIA PACIFIC: MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 103 LATIN AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 104 MIDDLE EAST: MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)
          TABLE 105 GCC COUNTRIES: MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
           6.4.1 GENE EXPRESSION ANALYSIS SERVICES
                    TABLE 106 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    6.4.1.1 RNA sequencing services
                               6.4.1.1.1 Rising technological advancements for drug discovery development to propel market
                                              TABLE 107 MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 108 NORTH AMERICA: MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 109 EUROPE: MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 110 ASIA PACIFIC: MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 111 LATIN AMERICA: MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                              TABLE 112 MIDDLE EAST: MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
                                              TABLE 113 GCC COUNTRIES: MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    6.4.1.2 Other services
                                TABLE 114 MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 115 NORTH AMERICA: MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 116 EUROPE: MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 117 ASIA PACIFIC: MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 118 LATIN AMERICA: MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 119 MIDDLE EAST: MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 120 GCC COUNTRIES: MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
           6.4.2 BIOINFORMATICS SOLUTIONS
                    6.4.2.1 Increasing demand for advanced data analytics to support market growth
                                TABLE 121 MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 122 NORTH AMERICA: MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 123 EUROPE: MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 124 ASIA PACIFIC: MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 125 LATIN AMERICA: MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 126 MIDDLE EAST: MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 127 GCC COUNTRIES: MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION (Page No. - 145)
    7.1 INTRODUCTION 
          TABLE 128 GENE EXPRESSION ANALYSIS INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
    7.2 DRUG DISCOVERY & DEVELOPMENT 
           7.2.1 INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET
                    TABLE 129 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 130 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 131 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 132 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 133 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 134 MIDDLE EAST: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 135 GCC COUNTRIES: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 CLINICAL DIAGNOSTICS 
           7.3.1 RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET
                    TABLE 136 MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 137 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 138 EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 139 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 140 LATIN AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 141 MIDDLE EAST: MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 142 GCC COUNTRIES: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 OTHER APPLICATIONS 
          TABLE 143 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 144 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 145 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 146 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 147 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 148 MIDDLE EAST: MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 149 GCC COUNTRIES: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8 GENE EXPRESSION ANALYSIS MARKET, BY END USER (Page No. - 158)
    8.1 INTRODUCTION 
          TABLE 150 GENE EXPRESSION ANALYSIS INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           8.2.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND
                    TABLE 151 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 152 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 153 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 154 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 155 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 156 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 157 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 ACADEMIC & RESEARCH INSTITUTES 
           8.3.1 INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET
                    TABLE 158 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 159 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 160 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 161 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 162 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 163 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 164 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 OTHER END USERS 
          TABLE 165 MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 166 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 167 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 168 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 169 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 170 MIDDLE EAST: MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 171 GCC COUNTRIES: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
9 GENE EXPRESSION ANALYSIS MARKET, BY REGION (Page No. - 171)
    9.1 INTRODUCTION 
          TABLE 172 GENE EXPRESSION ANALYSIS INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 31 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
          TABLE 173 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 174 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
          TABLE 175 NORTH AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 176 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 177 NORTH AMERICA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 178 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 179 NORTH AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 180 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.2.1 NORTH AMERICA: RECESSION IMPACT
           9.2.2 US
                    9.2.2.1 Rising expenditure on NGS-based research to drive market
                                TABLE 181 US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 182 US: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 183 US: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 184 US: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 185 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 186 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 187 US: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing incidence of chronic diseases to drive market
                                TABLE 188 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 189 CANADA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 190 CANADA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 191 CANADA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 192 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 193 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 194 CANADA: MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.3 EUROPE 
          TABLE 195 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 196 EUROPE: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
          TABLE 197 EUROPE: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 198 EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 199 EUROPE: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 200 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 201 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 202 EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.1 EUROPE: RECESSION IMPACT
           9.3.2 GERMANY
                    9.3.2.1 Rising investments in proteomics & genomics research to drive market
                                TABLE 203 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 204 GERMANY: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 205 GERMANY: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 206 GERMANY: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 207 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 208 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 209 GERMANY: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Favorable government support for genomic research projects to fuel market
                                TABLE 210 UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 211 UK: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 212 UK: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 213 UK: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 214 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 215 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 216 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.4 FRANCE
                    9.3.4.1 Increasing R&D in life sciences research to fuel market
                                TABLE 217 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 218 FRANCE: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 219 FRANCE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 220 FRANCE: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 221 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 222 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 223 FRANCE: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Favorable government support for industry-academia collaborations to support market growth
                                TABLE 224 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 225 ITALY: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 226 ITALY: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 227 ITALY: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 228 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 229 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 230 ITALY: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Growth in biomedical research to boost demand
                                TABLE 231 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 232 SPAIN: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 233 SPAIN: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 234 SPAIN: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 235 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 236 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 237 SPAIN: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 238 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                    TABLE 239 REST OF EUROPE: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 240 REST OF EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 241 REST OF EUROPE: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 242 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 243 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 244 REST OF EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 32 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
          TABLE 245 ASIA PACIFIC: MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 246 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
          TABLE 247 ASIA PACIFIC: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 248 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 249 ASIA PACIFIC: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 250 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 251 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 252 ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
           9.4.2 CHINA
                    9.4.2.1 Rising incidence of infectious diseases to boost demand
                                TABLE 253 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 254 CHINA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 255 CHINA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 256 CHINA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 257 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 258 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 259 CHINA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Rising technological advancements in sequencing systems to propel market
                                TABLE 260 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 261 JAPAN: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 262 JAPAN: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 263 JAPAN: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 264 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 265 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 266 JAPAN: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Robust growth in biopharmaceutical industry to drive market
                                TABLE 267 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 268 INDIA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 269 INDIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 270 INDIA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 271 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 272 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 273 INDIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.5 AUSTRALIA
                    9.4.5.1 Increasing focus on R&D expenditure to drive market
                                TABLE 274 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 275 AUSTRALIA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 276 AUSTRALIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 277 AUSTRALIA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 278 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 279 AUSTRALIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 280 AUSTRALIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.6 SOUTH KOREA
                    9.4.6.1 Rising prevalence of chronic diseases to boost demand
                                TABLE 281 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 282 SOUTH KOREA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 283 SOUTH KOREA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 284 SOUTH KOREA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 285 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 286 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 287 SOUTH KOREA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 288 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 289 REST OF ASIA PACIFIC: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 290 REST OF ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 291 REST OF ASIA PACIFIC: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 292 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 293 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 294 REST OF ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.5 LATIN AMERICA 
          TABLE 295 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 296 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
          TABLE 297 LATIN AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 298 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 299 LATIN AMERICA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 300 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 301 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 302 LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.5.1 LATIN AMERICA: RECESSION IMPACT
           9.5.2 BRAZIL
                    9.5.2.1 Growth in biopharmaceutical industry to support market
                                TABLE 303 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 304 BRAZIL: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 305 BRAZIL: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 306 BRAZIL: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 307 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 308 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 309 BRAZIL: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.5.3 MEXICO
                    9.5.3.1 Increasing incidence of diabetes and growing geriatric population to propel market
                                TABLE 310 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 311 MEXICO: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 312 MEXICO: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 313 MEXICO: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 314 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 315 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 316 MEXICO: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 317 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                    TABLE 318 REST OF LATIN AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 319 REST OF LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 320 REST OF LATIN AMERICA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 321 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 322 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 323 REST OF LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.6 MIDDLE EAST 
          TABLE 324 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 325 MIDDLE EAST: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
          TABLE 326 MIDDLE EAST: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 327 MIDDLE EAST: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 328 MIDDLE EAST: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 329 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 330 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 331 MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.6.1 MIDDLE EAST: RECESSION IMPACT
           9.6.2 GCC COUNTRIES
                    TABLE 332 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 333 GCC COUNTRIES: MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                    TABLE 334 GCC COUNTRIES: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 335 GCC COUNTRIES: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 336 GCC COUNTRIES: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 337 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 338 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 339 GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.1 Saudi Arabia
                               9.6.2.1.1 Increasing investments in pharmaceutical R&D to support market growth
                                              TABLE 340 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                              TABLE 341 SAUDI ARABIA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 342 SAUDI ARABIA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 343 SAUDI ARABIA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 344 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 345 SAUDI ARABIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 346 SAUDI ARABIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.2 United Arab Emirates
                               9.6.2.2.1 Growing R&D expenditure and advanced healthcare infrastructure to fuel market
                                              TABLE 347 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                              TABLE 348 UNITED ARAB EMIRATES: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 349 UNITED ARAB EMIRATES: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 350 UNITED ARAB EMIRATES: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 351 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 352 UNITED ARAB EMIRATES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 353 UNITED ARAB EMIRATES: MARKET, BY END USER, 2022–2029 (USD MILLION)
                    9.6.2.3 Other GCC Countries
                                TABLE 354 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                TABLE 355 OTHER GCC COUNTRIES: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 356 OTHER GCC COUNTRIES: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 357 OTHER GCC COUNTRIES: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 358 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 359 OTHER GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 360 OTHER GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.6.3 REST OF MIDDLE EAST
                    TABLE 361 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 362 REST OF MIDDLE EAST: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 363 REST OF MIDDLE EAST: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 364 REST OF MIDDLE EAST: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 365 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 366 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 367 REST OF MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.7 AFRICA 
           9.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
                    TABLE 368 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                    TABLE 369 AFRICA: MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 370 AFRICA: MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 371 AFRICA: MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 372 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 373 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 374 AFRICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
           9.7.2 AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE (Page No. - 263)
     10.1 INTRODUCTION 
     10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
             FIGURE 33 GENE EXPRESSION ANALYSIS: STRATEGIES DEPLOYED BY GENE EXPRESSION ANALYSIS PLAYERS
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021–2023)
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
             TABLE 375 GENE EXPRESSION ANALYSIS MARKET: INTENSITY OF COMPETITIVE RIVALRY
     10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 36 GENE EXPRESSION ANALYSIS INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             10.5.5 COMPANY FOOTPRINT ANALYSIS
                         FIGURE 37 GENE EXPRESSION ANALYSIS INDUSTRY: COMPANY FOOTPRINT (2023)
                         TABLE 376 GENE EXPRESSION ANALYSIS INDUSTRY: TYPE FOOTPRINT
                         TABLE 377 GENE EXPRESSION ANALYSIS INDUSTRY: REGIONAL FOOTPRINT
     10.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 38 GENE EXPRESSION ANALYSIS INDUSTRY: START-UP/SME EVALUATION MATRIX (2023)
     10.7 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 
             TABLE 378 GENE EXPRESSION ANALYSIS INDUSTRY: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 379 GENE EXPRESSION ANALYSIS INDUSTRY: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
     10.8 VALUATION AND FINANCIAL METRICS OF GENE EXPRESSION ANALYSIS VENDORS 
             FIGURE 39 EV/EBITDA OF KEY VENDORS
             FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 
             10.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
                         FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
     10.1 COMPETITIVE SCENARIO 
             10.10.1 PRODUCT LAUNCHES
                         TABLE 380 GENE EXPRESSION ANALYSIS INDUSTRY: PRODUCT LAUNCHES (JANUARY 2021–JANUARY 2024)
             10.10.2 DEALS
                         TABLE 381 GENE EXPRESSION ANALYSIS INDUSTRY: DEALS (JANUARY 2021–JANUARY 2024)
             10.10.3 EXPANSIONS
                         TABLE 382 GENE EXPRESSION ANALYSIS INDUSTRY: EXPANSIONS (JANUARY 2021–JANUARY 2024)
             10.10.4 OTHER DEVELOPMENTS
                         TABLE 383 GENE EXPRESSION ANALYSIS: OTHER DEALS/DEVELOPMENTS (JANUARY 2021–JANUARY 2024)
11 COMPANY PROFILES (Page No. - 281)
(Business overview, Products/Services offered, Recent developments & MnM View)*
     11.1 KEY PLAYERS 
             11.1.1 THERMO FISHER SCIENTIFIC INC.
                         TABLE 384 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                         FIGURE 42 THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2022)
                         TABLE 385 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
                         TABLE 386 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
                         TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS
             11.1.2 BIO-RAD LABORATORIES, INC.
                         TABLE 388 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
                         FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
                         TABLE 389 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
                         TABLE 390 BIO-RAD LABORATORIES, INC.: DEALS
             11.1.3 ILLUMINA, INC.
                         TABLE 391 ILLUMINA, INC.: COMPANY OVERVIEW
                         FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
                         TABLE 392 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
                         TABLE 393 ILLUMINA, INC.: OTHER DEVELOPMENTS
             11.1.4 QIAGEN
                         TABLE 394 QIAGEN: COMPANY OVERVIEW
                         FIGURE 45 QIAGEN: COMPANY SNAPSHOT (2022)
                         TABLE 395 QIAGEN: PRODUCTS/SERVICES OFFERED
                         TABLE 396 QIAGEN: PRODUCT LAUNCHES
                         TABLE 397 QIAGEN: DEALS
             11.1.5 F. HOFFMANN-LA ROCHE LTD.
                         TABLE 398 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
                         FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
                         TABLE 399 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
                         TABLE 400 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES
             11.1.6 REVVITY
                         TABLE 401 REVVITY: COMPANY OVERVIEW
                         FIGURE 47 REVVITY: COMPANY SNAPSHOT (2022)
                         TABLE 402 REVVITY: PRODUCTS/SERVICES OFFERED
                         TABLE 403 REVVITY: PRODUCT LAUNCHES
                         TABLE 404 REVVITY: DEALS
                         TABLE 405 REVVITY: OTHER DEVELOPMENTS
             11.1.7 PACBIO
                         TABLE 406 PACBIO: COMPANY OVERVIEW
                         FIGURE 48 PACBIO: COMPANY SNAPSHOT (2022)
                         TABLE 407 PACBIO: PRODUCTS/SERVICES OFFERED
                         TABLE 408 PACBIO: PRODUCT LAUNCHES
                         TABLE 409 PACBIO: DEALS
                         TABLE 410 PACBIO: OTHER DEVELOPMENTS
             11.1.8 AGILENT TECHNOLOGIES, INC.
                         TABLE 411 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                         FIGURE 49 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2023)
                         TABLE 412 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
                         TABLE 413 AGILENT TECHNOLOGIES, INC.: DEALS
                         TABLE 414 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS
             11.1.9 SYSMEX CORPORATION
                         TABLE 415 SYSMEX CORPORATION: COMPANY OVERVIEW
                         FIGURE 50 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
                         TABLE 416 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
                         TABLE 417 SYSMEX CORPORATION: DEALS
                         TABLE 418 SYSMEX CORPORATION: OTHER DEVELOPMENTS
             11.1.10 BGI
                         TABLE 419 BGI: COMPANY OVERVIEW
                         TABLE 420 BGI: PRODUCTS/SERVICES OFFERED
                         TABLE 421 BGI: DEALS
             11.1.11 EUROFINS SCIENTIFIC SE
                         TABLE 422 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW
                         FIGURE 51 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022)
                         TABLE 423 EUROFINS SCIENTIFIC SE: PRODUCTS/SERVICES OFFERED
                         TABLE 424 EUROFINS SCIENTIFIC SE: OTHER DEVELOPMENTS
             11.1.12 STANDARD BIOTOOLS
                         TABLE 425 STANDARD BIOTOOLS: COMPANY OVERVIEW
                         FIGURE 52 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
                         TABLE 426 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED
                         TABLE 427 STANDARD BIOTOOLS: PRODUCT LAUNCHES
             11.1.13 OXFORD NANOPORE TECHNOLOGIES PLC
                         TABLE 428 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
                         TABLE 429 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED
                         TABLE 430 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS
             11.1.14 GENSCRIPT
                         TABLE 431 GENSCRIPT: COMPANY OVERVIEW
                         FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT
                         TABLE 432 GENSCRIPT: PRODUCTS/SERVICES OFFERED
                         TABLE 433 GENSCRIPT: OTHER DEVELOPMENTS
             11.1.15 TAKARA BIO INC.
                         TABLE 434 TAKARA BIO INC.: COMPANY OVERVIEW
                         FIGURE 54 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
                         TABLE 435 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
                         TABLE 436 TAKARA BIO INC.: PRODUCT LAUNCHES
*Details on Business overview, Products/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 10X GENOMICS INC.
             11.2.2 ZYMO RESEARCH CORPORATION
             11.2.3 TWIST BIOSCIENCE
             11.2.4 PROMEGA CORPORATION
             11.2.5 LGC LIMITED
             11.2.6 CD GENOMICS
             11.2.7 NANOSTRING TECHNOLOGIES, INC.
             11.2.8 BIOSPYDER, INC
             11.2.9 INTEGRATED DNA TECHNOLOGIES, INC.
             11.2.10 NEW ENGLAND BIOLABS, INC.
12 APPENDIX (Page No. - 362)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS